Abstract B55: PIK3CA mutation enrichment and detection in clinical samples
The PI3K/AKT/mTOR signaling pathway is one of the most frequently mutated pathways in human cancers, including breast cancer. Given the current urge for more personalized approaches, there is an increasing need for a rigorous list of biomarkers and detection methods with advanced, less-invasive, rel...
Saved in:
Published in | Clinical cancer research Vol. 26; no. 11_Supplement; p. B55 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
01.06.2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!